menu search

Moore kuehn encourages vblt, radi, tcrr, and bte investors to contact law firm

NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New Y...

March 7, 2023, 3:40 pm

Moore kuehn encourages ptrs, vblt, indt, and jnce investors to contact law firm

NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New Yo...

February 28, 2023, 2:28 am

Lifshitz law pllc announces investigations of vblt, hrzn, infi, and meip

NEW YORK, Feb. 25, 2023 (GLOBE NEWSWIRE) — Vascular Biogenics Ltd. (NASDAQ: vblt) Lifshitz Law PLLC a...

February 26, 2023, 1:11 am

Why is vascular biogenics (vblt) stock up 52%?

Vascular Biogenics (NASDAQ: vblt ) stock is rocketing higher on Thursday following news of a merger wit...

February 23, 2023, 11:03 am

Why vascular biogenics stock is plunging

Vascular Biogenics Ltd (NASDAQ: vblt) shares are falling Wednesday after the company announced that th...

July 20, 2022, 9:44 am

Vascular biogenics (vblt) reports q1 loss, misses revenue estimates

Vascular Biogenics (vblt) delivered earnings and revenue surprises of -8.33% and 42.35%, respectively, ...

May 17, 2022, 9:47 am

Vascular biogenics ltd. (vblt) ceo dror harats on q4 2021 results - earnings call transcript

Vascular Biogenics Ltd. (vblt) CEO Dror Harats on Q4 2021 Results - Earnings Call Transcript...

March 23, 2022, 1:45 pm

Update -- vbl therapeutics to report year-end 2021 financial results on march 23

TEL AVIV, Israel and NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: vblt), a la...

March 14, 2022, 9:57 am

What makes vascular biogenics (vblt) a new buy stock

Vascular Biogenics (vblt) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...

November 18, 2021, 1:45 pm

What makes vascular biogenics (vblt) a new buy stock

Vascular Biogenics (vblt) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...

November 18, 2021, 1:45 pm

What makes vascular biogenics (vblt) a new buy stock

Vascular Biogenics (vblt) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...

November 18, 2021, 1:45 pm


Search within

Pages Search Results: